0000919574-13-006731.txt : 20131115 0000919574-13-006731.hdr.sgml : 20131115 20131115173018 ACCESSION NUMBER: 0000919574-13-006731 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131115 DATE AS OF CHANGE: 20131115 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43062 FILM NUMBER: 131224836 BUSINESS ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 BUSINESS PHONE: 714-786-4200 MAIL ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BROADWOOD PARTNERS LP CENTRAL INDEX KEY: 0001278386 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O BROADWOOD CAPITAL INC. STREET 2: 724 FIFTH AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-508-5735 MAIL ADDRESS: STREET 1: C/O BROADWOOD CAPITAL INC. STREET 2: 724 FIFTH AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13D/A 1 d1430489_13d-a.htm d1430489_13d-a.htm

 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, DC 20549
 

 
SCHEDULE 13D/A
THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)


Questcor Pharmaceuticals, Inc.
(Name of Issuer)


Common Stock
(Title of Class of Securities)


74835Y101
(CUSIP Number)

Neal C. Bradsher
c/o Broadwood Capital, Inc.
724 Fifth Avenue, 9th Floor
New York, New York 10019
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)


November 12, 2013
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13D-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [  ].
 
.

 
 

 


CUSIP No.
74835Y101
 

1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Broadwood Partners, L.P.  
 
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  [_]
   
(b)  [x]
     
3.
SEC USE ONLY
 
     
     
     
4.
SOURCE OF FUNDS*
 
     
 
WC, AF
 
     
5.   
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
[_]
     
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
Delaware
 
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
7.
SOLE VOTING POWER
 
     
 
0
 
     
8.   
SHARED VOTING POWER
 
     
 
2,796,660
 
     
9.
SOLE DISPOSITIVE POWER
 
     
 
0
 
     
10.
SHARED DISPOSITIVE POWER
 
     
 
2,796,660
 
     
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
     
 
2,796,660
 
     
12.  
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
     
13.  
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
     
 
4.6%
 
     
14.
TYPE OF REPORTING PERSON*
 
     
 
PN
 

 

 
 

 


CUSIP No.
74835Y101
 

1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Broadwood Capital, Inc.
 
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  [_]
   
(b)  [x]
     
3.
SEC USE ONLY
 
     
     
     
4.
SOURCE OF FUNDS*
 
     
 
WC, AF
 
     
5.   
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
[_]
     
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
New York
 
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
7.
SOLE VOTING POWER
 
     
 
0
 
     
8.   
SHARED VOTING POWER
 
     
 
2,796,660
 
     
9.
SOLE DISPOSITIVE POWER
 
     
 
0
 
     
10.
SHARED DISPOSITIVE POWER
 
     
 
2,796,660
 
     
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
     
 
2,796,660
 
     
12.  
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
     
13.  
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
     
 
4.6%
 
     
14.
TYPE OF REPORTING PERSON*
 
     
 
CO
 


 
 

 


CUSIP No.
74835Y101
 

1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Neal C. Bradsher
 
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  [_]
   
(b)  [x]
     
3.
SEC USE ONLY
 
     
     
     
4.
SOURCE OF FUNDS*
 
     
 
WC, AF, OO
 
     
5.   
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
[_]
     
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
U.S.A.
 
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
7.
SOLE VOTING POWER
 
     
 
259,417
 
     
8.   
SHARED VOTING POWER
 
     
 
2,796,660
 
     
9.
SOLE DISPOSITIVE POWER
 
     
 
259,417
 
     
10.
SHARED DISPOSITIVE POWER
 
     
 
2,796,660
 
     
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
     
 
3,056,077
 
     
12.  
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
     
13.  
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
     
 
5.0%
 
     
14.
TYPE OF REPORTING PERSON*
 
     
 
IN
 


 
 

 


CUSIP No.
74835Y101
 
 
 

Item 1.  Security and Issuer.

     Questcor Pharmaceuticals, Inc., Common Stock (the "Shares")

     1300 North Kellogg Drive, Suite D 
     Anaheim, California 92807
 

Item 2.  Identity and Background.

(a-c,f) This Schedule 13D is being filed by Broadwood Partners, L.P. ("Broadwood Partners"), Broadwood Capital, Inc. ("Broadwood Capital"), the general partner of Broadwood Partners and Neal C. Bradsher, the President of Broadwood Capital (each of Broadwood Partners, Broadwood Capital and Neal C. Bradsher may be referred to herein as a "Reporting Person" and collectively may be referred to as "Reporting Persons").  

Broadwood Partners is a Delaware limited partnership with its principal business address at 724 Fifth Avenue, 9th Floor, New York, New York 10019.  Broadwood Capital is a New York corporation with its principal business address at 724 Fifth Avenue, 9th Floor, New York, New York 10019.  Neal C. Bradsher is a United States citizen whose principal business address is c/o Broadwood Capital, Inc., 724 Fifth Avenue, 9th Floor, New York, New York 10019.

The Shares reported herein are held in the name of Broadwood Partners.  

     (d) None of the Reporting Persons have, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     (e) None of the Reporting Persons have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding were or are subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.


 Item 3.  Source and Amount of Funds or Other Consideration.

As of the date hereof Broadwood Partners may be deemed to beneficially own 2,796,660 Shares.  

As of the date hereof Broadwood Capital may be deemed to beneficially own 2,796,660 Shares.
     
As of the date hereof Neal C. Bradsher may be deemed to beneficially own 3,056,077 Shares.

No borrowed funds were used to purchase the Shares, other than any borrowed funds used for working capital purposes in the ordinary course of business.


 Item 4.  Purpose of Transaction.

The Reporting Persons acquired their Shares of the Issuer for investment purposes.  

The Reporting Persons have no plans or proposals which, other than as expressly set forth below, would relate to or would result in: (a) the acquisition of additional securities of the Issuer or the disposition of presently-owned securities of the Issuer; (b) any extraordinary corporate transaction involving the Issuer; (c) a sale or transfer of a material amount of assets of the Issuer; (d) any change in the present Board of Directors or management of the Issuer; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any material change in the operating policies or corporate structure of the Issuer; (g) any change in the Issuer's charter or by-laws; (h) the Shares of the Issuer ceasing to be authorized to be quoted in the over-the-counter security markets; or (i) causing the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934.  The Reporting Persons, however, reserve the right, at a later date, to effect one or more of such changes or transactions in the number of shares they may be deemed to beneficially own.

Neal C. Bradsher, a Reporting Person, serves on the Issuer's Board of Directors.
 
 
 
 

 
 
 
 

 Item 5.  Interest in Securities of the Issuer.

(a, b) As of the date hereof, Broadwood Partners may be deemed to be the beneficial owner of 2,796,660 Shares, constituting 4.6% of the Shares of the Issuer, based upon the 60,768,440 Shares outstanding as of September 30, 2013 (the Reporting Persons obtained the number of Shares outstanding in a discussion with the Issuer).

Broadwood Partners has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 2,796,660 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 2,796,660 Shares.
 
Broadwood Partners specifically disclaims beneficial ownership in the Shares reported herein except to the extent of its pecuniary interest therein.

(a, b) As of the date hereof, Broadwood Capital may be deemed to be the beneficial owner of 2,796,660 Shares, constituting 4.6% of the Shares of the Issuer, based upon the 60,768,440  Shares outstanding as of September 30, 2013 (the Reporting Persons obtained the number of Shares outstanding in a discussion with the Issuer).

Broadwood Capital has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 2,796,660 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 2,796,660 Shares.

Broadwood Capital specifically disclaims beneficial ownership in the Shares reported herein except to the extent of its pecuniary interest therein.

(a, b) As of the date hereof, Neal C. Bradsher may be deemed to be the beneficial owner of 3,056,077 Shares, constituting 5.0% of the Shares of the Issuer, based upon the 61,067,857 Shares outstanding1 as of September 30, 2013 (the Reporting Persons obtained the number of Shares outstanding in a discussion with the Issuer).

Neal C. Bradsher has the sole power to vote or direct the vote of 259,417 Shares; has the shared power to vote or direct the vote of 2,796,660 Shares; has sole power to dispose or direct the disposition of 259,417 Shares; and has shared power to dispose or direct the disposition of 2,796,660 Shares.

Neal C. Bradsher specifically disclaims beneficial ownership in the Shares reported herein except to the extent of his pecuniary interest therein.

(c) The trading dates, number of Shares purchased and sold and price per share for all transactions in the Shares by the Reporting Persons in the past 60 days are set forth in Exhibit B.

(d) N/A

(e) Broadwood Partners and Broadwood Capital, each a reporting person, ceased to be the beneficial owner of more than five percent of the Shares on November 12, 2013.  
 

 Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

N/A
________________________________________________________________________________________________
Item 7.  Material to be Filed as Exhibits.

Exhibit A: Agreement between the Reporting Persons to file jointly
Exhibit B: Transactions by the Reporting Persons during the past 60 Days
 
_________________________ 
1           The number of outstanding shares is based on the 60,768,440 Shares the Issuer reported outstanding as of September 30, 2013, adjusted for options held by Neal C. Bradsher.
 

 
 

 



SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Broadwood Partners, L.P.
By: Broadwood Capital, Inc.
By: Neal C. Bradsher, President

By: /s/ Neal C. Bradsher

 
Broadwood Capital, Inc.
By: Neal C. Bradsher, President

By: /s/ Neal C. Bradsher

 

/s/ Neal C. Bradsher

 Neal C. Bradsher
 

 
November 15, 2013



Attention.  Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).
 
 
 

 
 

 


Exhibit A


AGREEMENT

The undersigned agree that this Schedule 13D/A3 dated November 15, 2013 relating to the Common Stock of Questcor Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.

 
Broadwood Partners, L.P.
By: Broadwood Capital, Inc.
By: Neal C. Bradsher, President

By: /s/ Neal C. Bradsher

 
Broadwood Capital, Inc.
By: Neal C. Bradsher, President

By: /s/ Neal C. Bradsher

 
/s/ Neal C. Bradsher

 Neal C. Bradsher


 
 
November 15, 2013
 

 

 
 

 

Exhibit B
 
Transactions by the Reporting Persons during the past 60 Days
 
TRANSACTIONS IN THE SHARES
 
 
TRANSACTIONS BY BROADWOOD PARTNERS
Date of
Transaction
Number of Shares
Purchase/(Sold)
 
Price of Shares
11/11/2013
(130,122)
$62.2477(2)
11/12/2013
(195,844)
$62.2804(3)
11/13/2013
(174,034)
$62.5556(4)

 
TRANSACTIONS BY NEAL C. BRADSHER
Date of
Transaction
Number of Shares
Purchase/(Sold)
 
Price of Shares
11/14/2013
(15,000)
$62.3111(5)
11/14/2013
(25,000)
$62.4628(6)
 

_____________________
2
This constitutes the weighted average sale price. The prices range from $61.85 to $62.52. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
   
3 This constitutes the weighted average sale price. The prices range from $61.67 to $62.97. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
   
4
This constitutes the weighted average sale price. The prices range from $62.15 to $62.83. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
   
5
This constitutes the weighted average sale price. The prices range from $62.31  to $62.39.  The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
   
6
 
   
 
 
  

 
 

 


 
TRANSACTIONS IN OPTIONS THAT ARE EXERCISABLE INTO SHARES
 
EXERCISE OF OPTIONS BY NEAL C. BRADSHER
 
Date of
Exercise
Underlying
Number of Shares Received
 
Exercise Price
11/14/2013
 15,000  $0.90
11/14/2013
25,000
$0.83

 
 
 
 
 

SK 22056 0001 1430489